文献速递美容整形

经皮与经结膜双入路微创重睑成形联合上睑下垂矫正的回顾性综述

A retrospective review of transcutaneous and transconjunctival dual approach-A technique for mini-invasive double eyelid blepharoplasty with blepharoptosis correction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-11-28

该回顾性研究回顾了2018年11月至2019年5月间接受微创重睑成形联合上睑下垂矫正的159只眼睑,描述了经皮与经结膜双入路技术并比较其与单一入路的疗效。双入路组47只眼睑的睑缘反射距离1(MRD1)和提上睑肌功能(LF)显著改善(p<0.05),相同收紧量下双入路MRD1改善1.6±0.7 mm,约为单纯经结膜入路的近两倍;双入路组6个月随访内无修整或并发症。结论认为双入路技术适用范围广、有效且修整率低。

要点

  • 双入路组47只眼睑的MRD1和LF显著改善(p<0.05),适用于任何程度上睑下垂患者。
  • 相同收紧量下,双入路实现MRD1改善1.6±0.7 mm,约为单纯经结膜入路的近两倍。
  • 双入路组6个月随访内无修整或并发症记录。

核心结论

  • 双入路技术适用范围广、有效且修整率低,可同时矫正上睑下垂并形成重睑。

研究设计与样本

  • 回顾性研究,回顾2018年11月至2019年5月间接受微创重睑成形联合上睑下垂矫正的159只眼睑,包含技术描述和手术结果。

主要发现

  • 双入路组47只眼睑的MRD1和LF显著改善(p<0.05),对应任何程度上睑下垂的患者。
  • 相同收紧量下,双入路可实现MRD1改善1.6±0.7 mm,约为单纯经结膜入路的近两倍。
  • 双入路组6个月随访内无修整或并发症记录。

关键数值与推荐

  • 双入路组47只眼睑的MRD1和LF改善具有统计学意义(p<0.05)。
  • 相同收紧量下,双入路MRD1改善1.6±0.7 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many Oriental eyes feature single eyelid fold and ptotic eyelid. Performing the double eyelid blepharoplasty (DEB) in a minimally invasive manner with simultaneous blepharoptosis correction (BPC) is important to achieve an aesthetic pleasing outcome. OBJECTIVE: To demonstrate an effective mini-invasive transcutaneous and transconjunctival dual approach technique for simultaneous DEB and BPC. Furthermore, to compare the outcome of BPC in dual approach, transcutaneous procedure and transconjunctival procedure. METHODS: This is a retrospective study reviewing 159 eyelids that underwent mini-invasive DEB with BPC from November 2018 to May 2019, including the technical description and the surgical outcomes. To investigate the efficacy, the pre- and postoperative margin reflex distance 1 (MRD1) and levator function (LF) corresponding to the different surgical procedures and preoperative severity was analyzed. RESULTS: Statistically, the dual approach group has significant improvement in MRD1 and LF (47 eyelids, p<0.05) corresponding to patients with ptosis of any severity. Under the same tucking amount, dual approach can achieve 1.6±0.7 mm of MRD1 improvement, which is nearly twice the amount compare with transconjunctival approach alone. No revision nor complication noted in the dual approach group by 6-month follow-up. CONCLUSION: The dual approach technique is a method with a wide range of applications, effective, and low revision rate that simultaneously correct blepharoptosis and create a double eyelid.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Wang YH, Lee MC, Chang SL, et al. A retrospective review of transcutaneous and transconjunctival dual approach-A technique for mini-invasive double eyelid blepharoplasty with blepharoptosis correction. J Plast Reconstr Aesthet Surg. 2021. PMID: 34930703. doi:10.1016/j.bjps.2021.11.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。